Turning Point Therapeutics logo

Turning Point Therapeutics

ID: 5331714

Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies

7

Funding Rounds

$720.7m

Money raised

Overview

Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Turning Point Therapeutics has raised a total of $99.4m in funding over 7 rounds.

Key Insights:

  • Turning Point Therapeutics Venture round, October 19, 2018: $80m
  • Turning Point Therapeutics Series B round, March 21, 2016: $18m
  • Turning Point Therapeutics Venture round, January 6, 2014: $1.4m
  • Turning Point Therapeutics Venture round, September 2019: $202.5m
  • TP Therapeutics funding round, May 2017: $45m
  • Turning Point Therapeutics Venture round, May 2020: $373.8m